Culturally Tailored Diabetes Prevention for Prediabetes
(FIT4ALL Trial)
Trial Summary
What is the purpose of this trial?
African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in the battle against DM is the Diabetes Prevention Program (DPP), an evidence-based intervention that significantly delays or prevents Type 2 diabetes through the promotion of diet change, exercise and modest weight loss. However, weight loss from the DPP among AAs is about half that of White participants, and suboptimal AA attendance is a critical contributor. The investigators propose to conduct a study that will address social determinants (SD) that challenge DPP attendance with underserved African Americans from a safety net hospital. The investigators will examine DPP attendance and weight loss with participants randomized to 3 groups: standard DPP, a culturally-tailored DPP to address acceptability, and a culturally-tailored DPP enhanced to address socioeconomic-related barriers to DPP participation. This novel study is the first to tailor the DPP to address SD cultural and socioeconomic barriers that limit DPP attendance and reduce its effectiveness on outcomes. The proposed multidimensional, SD tailored DPP has great potential to be a feasible and scalable model to reduce DM risks among urban, African Americans and ultimately reduce DM disparities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Culturally Tailored Diabetes Prevention Program treatment?
Research shows that culturally tailored Diabetes Prevention Programs (DPP) can effectively reduce diabetes risk in diverse communities, such as Chinese Americans and Latinos, by adapting the program to fit cultural and linguistic needs. These adaptations have been successful in helping people achieve goals like increased physical activity and weight loss, which are important for preventing diabetes.12345
Is the Culturally Tailored Diabetes Prevention Program safe for humans?
The Diabetes Prevention Program (DPP) and its culturally tailored versions have been widely implemented and studied, showing effectiveness in reducing diabetes risk through lifestyle changes like healthy eating and physical activity. While the studies focus on effectiveness, they do not report any safety concerns, suggesting that the program is generally safe for humans.12467
What makes the Culturally Tailored Diabetes Prevention Program unique compared to other treatments for prediabetes?
Research Team
Jannette Y Berkley-Patton, PhD
Principal Investigator
University of Missouri-Columbia
Eligibility Criteria
This trial is for African Americans who are overweight (BMI > 24) and have prediabetes, a history of gestational diabetes, or a high risk for prediabetes. It's not open to those who are pregnant, non-English speakers, diagnosed with diabetes, planning pregnancy soon, currently in another weight loss program or have certain medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a standard DPP, a culturally tailored DPP, or a culturally tailored DPP enhanced with socioeconomic supports over 12 months
Follow-up
Participants are monitored for weight loss, physical activity, and other health outcomes
Treatment Details
Interventions
- Culturally Tailored Diabetes Prevention Program
- Culturally Tailored DPP Enhanced with Socioeconomic Supports
- Diabetes Prevention Program
Culturally Tailored Diabetes Prevention Program is already approved in United States for the following indications:
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri, Kansas City
Lead Sponsor
University Health
Collaborator
University of Kansas
Collaborator
University of Massachusetts, Amherst
Collaborator
Children's Mercy Hospital Kansas City
Collaborator